References
Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, Miller RG, Griffin JW (1993) Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 33:237–242
Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE (2000) Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 55:1256–1262
Kallenberg CG (2007) A 10 % ready-touse intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency. Clin Exp Immunol 150:437–441
Medical Research Council (1979) Aids to the Examination of the Peripheral Nervous System. London, England: HMSO, pp 1–2
Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596–601
Van Asseldonk JT, Franssen H, Van den Berg-Vos RM, Wokke JH, Van den Berg LH (2005) Multifocal motor neuropathy. Lancet Neurol 4:309–319
Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, Jennekens FG, Wokke JH (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59:248–252
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cats, E.A., van der Pol, WL., Piepers, S. et al. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy. J Neurol 255, 1598–1599 (2008). https://doi.org/10.1007/s00415-008-0979-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0979-3